Novi, Mich.-based DexKo Global Inc., which manufactures trailer running gear, chassis assemblies and related components, has acquired Osceola, Ind.-based injection molder Horizon Plastics & ...
Horizon Therapeutics plc Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA® (pegloticase injection) in Combination with Methotrexate to Increase Response Rates and Duration of Therapy ...
Canadian eVTOL developer Horizon Aircraft has obtained an $8.4 million funding injection from a strategic investor. The company is working on a hybrid eVTOL designated the Cavorite X7, which will use ...
-- Submission based on recent results from the MIRROR randomized clinical trial, which showed a 71% response rate for patients randomized to receive KRYSTEXXA plus methotrexate -- “Horizon has ...
-- The AGILE trial is designed based on patient and clinician input and part of Horizon’s continued investment to impact the KRYSTEXXA patient experience -- DUBLIN--(BUSINESS WIRE)-- Horizon ...
DUBLIN-- (BUSINESS WIRE)--Horizon Pharma plc (Nasdaq: HZNP) enrolled the first patient in a clinical trial evaluating the use of KRYSTEXXA® (pegloticase injection) with methotrexate to sustain lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results